Re: Cox et al. Development and evaluation of a novel product to remove surface contamination of hazardous drugs Reply

被引：1
|
作者：
Zamboni, William C. [1 ,2 ,3 ,4 ]
Salch, Stephanie A. [1 ]
Cox, Joshua [5 ]
Eckel, Stephen [1 ,4 ,6 ]
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
[2] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA
[3] Univ N Carolina, Carolina Ctr Canc Nanotechnol Excellence, Chapel Hill, NC 27599 USA
[4] ChemoGLO LLC, Chapel Hill, NC 27517 USA
[5] Dayton Phys Network, Dayton, OH USA
[6] Univ North Carolina Hosp, Chapel Hill, NC USA
来源：
JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2017年 / 23卷 / 07期
关键词：
CLOSED-SYSTEM DEVICE; ANTINEOPLASTIC DRUGS; HOSPITAL PHARMACIES; WORK-ENVIRONMENT; CYCLOPHOSPHAMIDE; EXPOSURE; IMPLEMENTATION; REDUCTION; AGENTS;
D O I：
10.1177/1078155217724650
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：558 / 560
页数：3
相关论文
共 50 条
  • [1] Re: Cox et al. Development and evaluation of a novel product to remove surface contamination of hazardous drugs
    Siderov, Jim
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (07) : 557 - 558
  • [2] Development and evaluation of a novel product to remove surface contamination of hazardous drugs
    Cox, Joshua
    Speed, Vonni
    O'Neal, Sara
    Hasselwander, Terry
    Sherwood, Candice
    Eckel, Stephen F.
    Zamboni, William C.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (02) : 103 - 115
  • [3] Reply to Hausner et al. Re: use of text mining tools in the development of search strategiesdcomparison of different approaches
    Paynter, Robin A.
    Featherstone, Robin
    Stoeger, Elizabeth
    Fiordalisi, Celia
    Voisin, Christiane
    Adam, Gaelen P.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 149 : 256 - 257
  • [4] Re: Mehta et al.: Vitreous evaluation: a diagnostic challenge (Ophthalmology 2015;122:531-7) REPLY
    Laver, Nora V.
    OPHTHALMOLOGY, 2016, 123 (01) : E5 - E5
  • [5] Considerations in seasonal variation studies in IBD and re-evaluation of Aratari et al.'s seasonality results - Reply
    Aratari, A.
    Caprilli, R.
    Papi, C.
    DIGESTIVE AND LIVER DISEASE, 2006, 38 (09) : 711 - 711
  • [6] Re: Bevill et al.: The Modern Metabolic Stone Evaluation in Children (Urology 2017;101:15-20) Reply
    Storm, Douglas W.
    UROLOGY, 2017, 102 : 268 - 269
  • [7] Re: Das et al.: Diabetic macular edema: pathophysiology and novel therapeutic targets (Ophthalmology 2015;122:1375-94) Reply
    Das, Arup
    OPHTHALMOLOGY, 2016, 123 (04) : E28 - E28
  • [8] In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Petar Suton
    Marko Skelin
    Zoran Rakusic
    Stjepan Dokuzovic
    Ivica Luksic
    European Archives of Oto-Rhino-Laryngology, 2019, 276 : 2113 - 2114
  • [9] In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Suton, Petar
    Skelin, Marko
    Rakusic, Zoran
    Dokuzovic, Stjepan
    Luksic, Ivica
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (07) : 2113 - 2114
  • [10] Re: Biomonitoring great, but do it the right way! Re: Poupeau et al. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.Reply
    Tanguay, C.
    Bussieres, J. F.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (01) : 252 - 253
12345